Targeting interleukin-21 in inflammatory diseases

Author： Sarra Massimiliano Franzèè Eleonora Pallone Francesco Monteleone Giovanni

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.6, 2011-06, pp. : 695-702

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-21 in Immune and Allergic Diseases

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 4, 2012-08 ,pp. : 313-319

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting selectins for the treatment of inflammatory diseases

By Impellizzeri Daniela Cuzzocrea Salvatore

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 1, 2014-01 ,pp. : 55-67

Informa Healthcare

Access to resources Recommend Favorite

Targeting Interleukin-21 in Immune-Mediated Pathologies

Current Drug Targets, Vol. 11, Iss. 5, 2010-05 ,pp. : 645-649

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-25: Key Regulator of Inflammatory and Autoimmune Diseases

Current Pharmaceutical Design, Vol. 17, Iss. 34, 2011-11 ,pp. : 3781-3785

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic targeting of adenosine receptors in inflammatory diseases

By Shanley T.P. Bshesh K.

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 4, 2000-08 ,pp. : 447-458

Informa Healthcare

Access to resources Recommend Favorite